account...no better than simvastatin at reopening arteries and a separate study reported this week found that Abbott...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ABBOTT LABORATORIES
Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.
Abbott Laboratories is part of Business Exchange, suggested by
Maki Yamasaki.
This topic contains
1,192 news
and
447 blog
items.
Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Americas Medical Products Companies. ABT.N Abbott Laboratories. BAX.N Baxter International. BSX.N Boston Scientific.
...business to Mova GmbH, the India veterinary business to Vetoquinol SA of France, and the nutrition business to...
So did diversified firms such as Bayer, Abbott Laboratories and Novartis.
Doctors said they'll be looking more favorably on niacin treatment, now that Arbiter showed Abbott Laboratories'...
...rated A/Negative/A-1 by Standard & Poor`s [S&P]) to Abbott Laboratories (Abbott; rated AA/Stable/A-1+ by...
Updated Date: Nov 13, 2009 EST...
208 patients, found that a controlled-release version of the B vitamin niacin, made by Abbott Laboratories (which...
Abbott Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan. Reported by FOXNews.
As readers will recall, this is the case where Centocor obtained a large infringement verdict against defendant Abbott...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details. (CNBC)Abbott...
Arbiter 6-Halts, a study that pitted Abbott Laboratories’ (ABT) Niaspan against Merck & Co’s (MRK) Zetia, has...
Abbott Laboratories' Niaspan pill did indeed beat out Merck's Zetia at unclogging arteries, according to study results...
A new trial found a reduction in the thickness of artery walls in patients given Abbott Laboratories' (ABT) Niaspan,...
Zetia, Merck's (MRK) cholesterol drug, suffered a setback after a new study found that Abbott Laboratories' (ABT)...
...cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of therapy with Abbott's...
North American Medical Supplies. North American Medical Products Companies. ABT.N Abbott Laboratories Subjects.
[CRRC] Stock Analysis: Abbott Laboratories [ABT] More Stock Analyses This article was written by Dividends4Life.
Nov. 16 (Bloomberg) -- A finding that Merck & Co.’s cholesterol pills Vytorin and Zetia didn’t reopen clogged...
Both are sold by Merck & Co. of Whitehouse Station, N.J. Niaspan is made by North Chicago, Ill.-based Abbott...
Abbott Laboratories (NYSE: ABT) opened at $53.39. So far today, the stock has hit a low of $53.01 and a high of $53.80.
NEW YORK, November 12 (newratings.com) - Analysts at Wedbush Morgan initiate coverage of Abbott Laboratories (ticker:...
(AP) — Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as...
The got beat out by Abbott Laboratories but the community of artists showed their support.
Top Sources: Abbott Laboratories
- DailyMed Drug Label Updates for the last seven days (since Jan 6, 2009 EST)
- Bio Job Blog
- pfblogs.org: The Ad-Free Personal Finance Blogs Aggregator
- Ottawa Citizen
- BigBlog.com: IP & Patents
- Intellectual Property Law
- Medical Device Recalls since January 11, 2009
- GuruFocus Updates
- UBS Research: Healthcare
- Business
Post a Job
Jobs in this Topic
DIRECTOR, GLOBAL MARKET RESEARCH & COMPETITIVE INTELLIGENCE
Abbott Laboratories
|
Alameda, CA
Posted: Nov 21
